-PTI Kolkata: The Election Commission in West Bengal today moved the Calcutta Hight Court seeking rejection of the government notification on poll schedule as the state government decided to contest it. The State Election Commission in its petition claimed that Section 42 of the West Bengal Panchayat Election Act, which states that the state government is empowered to notify election in consultation with the commission, is unconstitutional. The commission also prayed that it...

-The Hindu   Despite apparent similarities, the reports of two centrally appointed committees are split on the relationship between knowledge, skills and social needs Two major reports with overlapping concerns were submitted to the central government during the last decade. They were drafted by committees appointed by two different offices of the same government. One was chaired by Yash Pal, and the other by Sam Pitroda. The titles of the two committees indicated...

-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...

-The Hindu   Success stories from the right to education law give no joy when assessments show that children are ill-versed in the 3Rs and classrooms remain discriminatory Three years ago today, India, for the first time in history, made a promise to its children. With the Right of Children to Free and Compulsory Education coming into effect on April 1, 2010, every child was guaranteed the fundamental right to eight years of...

-IANS The Supreme Court on Monday dismissed Swiss pharmaceutical chain Novartis AG's petition seeking patent protection for its anti-cancer drug, Glivec (IMAtinib mesylate). The apex court bench of Justices Aftab Alam and Ranjana Prakash Desai dismissed with cost Novartis' plea challenging the Intellectual Property Appellate Board's decision declining the plea for patent of the drug that is used in the treatment of chronic myeloid leukaemia and malignant gastrointestinal stromal tumours. The patent...